Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 3
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04053816Phase 3Completed

Prevention of Dysrhythmias on the Cardiac Intensive Care Unit - Does Maintenance of High-normal Serum Potassium Levels Matter

Role: collaborator

NCT05212155Not ApplicableActive Not Recruiting

RYSE Family-based Behavioral Treatment for Childhood Obesity

Role: collaborator

NCT02579070Not ApplicableCompleted

Diabetic Foot Ulcer Prevention System (DFUPS) - Part 2

Role: collaborator

NCT02317835Phase 1Completed

Diabetic Foot Ulcer Prevention System

Role: collaborator

All 4 trials loaded